Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2301 Erwin Rd
Durham, NC 27705Phone+1 919-668-8917
Summary
- Dr. Manesh Patel is the Chief, Division of Cardiology at Duke University in Durham, NC and is affiliated with multiple hospitals in the area, including Duke Raleigh Hospital, Central Carolina Hospital, Duke Regional Hospital, and Duke University Hospital. He received his medical degree from Emory University School of Medicine and has been in practice 20 years. He specializes in and interventional cardiology and is experienced in valvular heart disease, interventional cardiology, cardiac catheterization, and peripheral arterial disease.
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 2002 - 2006
- Duke Univ Med Ctr2001 - 2001
- Duke University HospitalResidency, Internal Medicine, 1998 - 2000
- Duke University HospitalInternship, Internal Medicine, 1997 - 1998
- Emory University School of MedicineClass of 1997
Certifications & Licensure
- NC State Medical License 1997 - 2025
- VA State Medical License 2002 - 2006
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Distinguished Richard Stack Professor of Cardiology Duke University, 2020
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- PROspective Multicenter Imaging Study for Evaluation of Chest Pain Start of enrollment: 2010 Jul 01
- Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE) Start of enrollment: 2013 Sep 26
- Coronary Orbital Atherectomy System Study Start of enrollment: 2014 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsCYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID TrialJ. Antonio Gutierrez, Gretchen M. Heizer, W. Schuyler Jones, Frank W. Rockhold, Kenneth W. Mahaffey
American Heart Journal. 2020-08-16 - 114 citationsSafety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, d...Jonathan P Piccini, Valeria Caso, Stuart J Connolly, Keith A A Fox, Jonas Oldgren
Lancet. 2022-04-09 - 98 citationsDirect Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Tes...Anthony P Carnicelli, Hwanhee Hong, Stuart J Connolly, John Eikelboom, Robert P Giugliano
Circulation. 2022-01-25
Journal Articles
- Rivaroxaban versus warfarin in non-valvular atrial fibrillationPatel, MR, Mahaffey, KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JP, Berkowitz SD, Fox KAA, ..., N Engl J Med, 8/10/2011
- Potential Association of the ISCHEMIA Trial with the Appropriate Use Criteria Ratings for Percutaneous Coronary Intervention in Stable Ischemic Heart DiseaseJohn A Spertus, Manesh R Patel, JAMA Internal Medicine
- Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical RevascularizationKenneth Mahaffey, Manesh R Patel, W Schuyler Jones, William R Hiatt, Jeffrey S Berger, ScienceDirect
- Join now to see all
Authored Content
- ACC Appropriate Use Criteria Methodology: 2018 Update A Report of the American College of Cardiology Appropriate Use Criteria Task ForceFebruary 2018
- Antithrombotic Therapy in Peripheral Artery Disease Generating and Translating Evidence into PracticeJanuary 2018
Press Mentions
- JACC Edge Podcast | Innovations in Interventional Cardiology: Frightfully DelightfulOctober 23rd, 2024
- The Rising Tide of Atrial Fibrillation: Is Primary Care Ready?October 23rd, 2024
- Will OCEANIC-AF Sink Factor XI Inhibitors?September 17th, 2024
- Join now to see all
Committees
- Chair, ACC Appropriate Use Criteria 2014 - 2016
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: